These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8123949)

  • 1. Vancomycin clearance: an effect of prolonged therapy.
    Capers CC; Howard CE; Cassidy RW; Bess DT; Powers JS
    Ann Pharmacother; 1994 Jan; 28(1):116. PubMed ID: 8123949
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
    Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
    Nakayama H; Echizen H; Tanaka M; Sato M; Orii T
    Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of vancomycin clearance on renal function via regression and bootstrap methods.
    Zellner D; Zellner GE; Keller F
    J Clin Pharm Ther; 1998 Apr; 23(2):107-13. PubMed ID: 9786096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
    Yamamoto M; Kuzuya T; Baba H; Yamada K; Nabeshima T
    J Clin Pharm Ther; 2009 Aug; 34(4):473-83. PubMed ID: 19583681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
    Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
    Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial dosage of vancomycin in neutropenic hematologic patients].
    Soto J; Alsar MJ; Sacristán JA
    Sangre (Barc); 1992 Jun; 37(3):181-4. PubMed ID: 1440095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
    Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin.
    Minkutė R; Briedis V; Steponavičiūtė R; Vitkauskienė A; Mačiulaitis R
    J Clin Pharm Ther; 2013 Dec; 38(6):462-7. PubMed ID: 23924288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictions of serum vancomycin concentrations by means of six different equations for calculation of creatinine clearance.
    Wu G; Furlanut M
    Int J Clin Pharmacol Res; 1997; 17(1):1-10. PubMed ID: 9403347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients.
    Okamoto G; Sakamoto T; Kimura M; Ukishima Y; Sonoda A; Mori N; Kato Y; Maeda T; Kagawa Y
    Clin Biochem; 2007 Apr; 40(7):485-90. PubMed ID: 17336280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of vancomycin by continuous arteriovenous hemofiltration.
    Lau AH; John E
    Child Nephrol Urol; 1988-1989; 9(4):232-5. PubMed ID: 3255486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
    Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
    Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
    Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
    Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral activated charcoal on vancomycin clearance in rabbits with acute renal failure.
    el-Sayed YM; Niazy EM; Tawfik AF; al-Dardiri MM
    Drugs Exp Clin Res; 1993; 19(1):19-24. PubMed ID: 8223136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.